Artificial heart launch imminent
This article was originally published in The Gray Sheet
Abiomed plans to launch its AbioCor artificial heart in four to five U.S. hospitals in the next several months now that the firm has gained supplemental approval from FDA for upgrades to the humanitarian use device. The product was awarded a humanitarian device exemption in September 2006 for biventricular heart failure support in patients not eligible for a transplant (1"The Gray Sheet" Sept. 11, 2006, p. 9)
You may also be interested in...
CMS is proposing to pay for artificial hearts for the first time in 22 years, but only in certain clinical trials
The first fully implantable artificial heart, more than 25 years in the making, received approval from FDA Sept. 5 as a humanitarian-use device
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.